MicroRNAs: Promising Potential Targets for Cancer Treatment


avatar Mohammad Hashemi ORCID 1 , 2 , *

Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Hashemi M. MicroRNAs: Promising Potential Targets for Cancer Treatment. Gene Cell Tissue. 2016;3(4):e42864. https://doi.org/10.17795/gct-42864.


  • 1.

    Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97. [PubMed ID: 14744438].

  • 2.

    Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-69. [PubMed ID: 16557279]. https://doi.org/10.1038/nrc1840.

  • 3.

    Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524-9. [PubMed ID: 12434020]. https://doi.org/10.1073/pnas.242606799.

  • 4.

    Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1-12. [PubMed ID: 16989803]. https://doi.org/10.1016/j.ydbio.2006.08.028.

  • 5.

    Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-5. [PubMed ID: 15372042]. https://doi.org/10.1038/nature02871.

  • 6.

    He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522-31. [PubMed ID: 15211354]. https://doi.org/10.1038/nrg1379.

  • 7.

    Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495-500. [PubMed ID: 15806104]. https://doi.org/10.1038/ng1536.

  • 8.

    Mocellin S, Pasquali S, Pilati P. Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem. 2009;9(1):70-80. [PubMed ID: 19149661].

  • 9.

    Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125-9. [PubMed ID: 18278031]. https://doi.org/10.1038/nature06607.

  • 10.

    Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX, et al. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene. 2013;32(25):3071-9. [PubMed ID: 22824797]. https://doi.org/10.1038/onc.2012.318.

  • 11.

    Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010;136(1):1-15. [PubMed ID: 20223711]. https://doi.org/10.1016/j.clim.2010.02.005.

  • 12.

    Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007;104(9):3300-5. [PubMed ID: 17360642]. https://doi.org/10.1073/pnas.0611347104.

  • 13.

    Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics. 2007;8(12):1625-7. [PubMed ID: 18085993]. https://doi.org/10.2217/14622416.8.12.1625.

  • 14.

    Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle. 2008;7(7):853-8. [PubMed ID: 18414050]. https://doi.org/10.4161/cc.7.7.5666.

  • 15.

    Hashemi M, Sanaei S, Mashhadi MA, Hashemi SM, Taheri M, Ghavami S. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population. Cell Mol Biol (Noisy-le-grand). 2015;61(8):69-73. [PubMed ID: 26718432].

  • 16.

    Sanaei S, Hashemi M, Rezaei M, Hashemi SM, Bahari G, Ghavami S. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk. Biomed Rep. 2016;5(1):125-9. [PubMed ID: 27347415]. https://doi.org/10.3892/br.2016.690.

  • 17.

    Hashemi M, Sanaei S, Rezaei M, Bahari G, Hashemi SM, Mashhadi MA, et al. miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation. Exp Oncol. 2016;38(1):57-9. [PubMed ID: 27031722].

  • 18.

    Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):259-67. [PubMed ID: 24521023]. https://doi.org/10.2217/bmm.13.118.

  • 19.

    Zhu W, Zhao J, He J, Qi D, Wang L, Ma X, et al. Genetic variants in the MicroRNA biosynthetic pathway Gemin3 and Gemin4 are associated with a risk of cancer: a meta-analysis. PeerJ. 2016;4:1724. [PubMed ID: 27019773]. https://doi.org/10.7717/peerj.1724.

  • 20.

    Hashemi M, Moradi N, Ziaee SA, Narouie B, Soltani MH, Rezaei M, et al. Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population. J Adv Res. 2016;7(3):491-8. [PubMed ID: 27222754]. https://doi.org/10.1016/j.jare.2016.03.008.

  • 21.

    Hashemi M, Sheybani-Nasab M, Naderi M, Roodbari F, Taheri M. Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report. Tumour Biol. 2014;35(10):10375-9. [PubMed ID: 25048968]. https://doi.org/10.1007/s13277-014-2359-1.

  • 22.

    Hasani SS, Hashemi M, Eskandari-Nasab E, Naderi M, Omrani M, Sheybani-Nasab M. A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumour Biol. 2014;35(1):219-25. [PubMed ID: 23888320]. https://doi.org/10.1007/s13277-013-1027-1.

  • 23.

    Yin Z, Cui Z, Ren Y, Xia L, Wang Q, Zhang Y, et al. Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population. Lung Cancer. 2016;94:15-21. [PubMed ID: 26973201]. https://doi.org/10.1016/j.lungcan.2016.01.013.

  • 24.

    Xu L, Tang W. Associations of Polymorphisms in mir-196a2, mir-146a and mir-149 with Colorectal Cancer Risk: A Meta-Analysis. Pathol Oncol Res. 2016;22(2):261-7. [PubMed ID: 26208586]. https://doi.org/10.1007/s12253-014-9843-1.

  • 25.

    Wang W, Qin H, Zhou L, Ma J. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians. J Cancer Res Ther. 2016;12(2):676-80. [PubMed ID: 27461631]. https://doi.org/10.4103/0973-1482.154002.

  • 26.

    Ren YG, Zhou XM, Cui ZG, Hou G. Effects of common polymorphisms in miR-146a and miR-196a2 on lung cancer susceptibility: a meta-analysis. J Thorac Dis. 2016;8(6):1297-305. [PubMed ID: 27293850]. https://doi.org/10.21037/jtd.2016.05.02.

  • 27.

    Liu H, Zhou Y, Liu Q, Xiao G, Wang B, Li W, et al. Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects. Oncotarget. 2016. [PubMed ID: 27223084]. https://doi.org/10.18632/oncotarget.9509.

  • 28.

    Ji HH, Hong L, Huang GL, Yin HX, Xu P, Luo SY, et al. Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis. Meta Gene. 2015;3:14-25. [PubMed ID: 26925372]. https://doi.org/10.1016/j.mgene.2014.12.001.

  • 29.

    Zhang X, He R, Ren F, Tang R, Chen G. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis. J BUON. 2015;20(3):829-41. [PubMed ID: 26214637].

  • 30.

    Zhang P, Wang J, Lu T, Wang X, Zheng Y, Guo S, et al. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population. Tumour Biol. 2015;36(11):8789-95. [PubMed ID: 26055141]. https://doi.org/10.1007/s13277-015-3422-2.

  • 31.

    Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, et al. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016;29(4):330-46. [PubMed ID: 26916073]. https://doi.org/10.1038/modpathol.2016.38.

  • 32.

    Benderska N, Dittrich AL, Knaup S, Rau TT, Neufert C, Wach S, et al. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis. 2015;21(9):2039-51. [PubMed ID: 26083618]. https://doi.org/10.1097/MIB.0000000000000453.

  • 33.

    Qiu X, Zhu H, Liu S, Tao G, Jin J, Chu H, et al. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. J Gastroenterol Hepatol. 2016. [PubMed ID: 27529338]. https://doi.org/10.1111/jgh.13533.

  • 34.

    Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y. Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysis. Onco Targets Ther. 2016;9:2615-24. [PubMed ID: 27226723]. https://doi.org/10.2147/OTT.S103893.

  • 35.

    Li C, Sun J, Xiang Q, Liang Y, Zhao N, Zhang Z, et al. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis. J Neurooncol. 2016. [PubMed ID: 27531352]. https://doi.org/10.1007/s11060-016-2233-7.

  • 36.

    Liang Y, Yang W, Zhu Y, Yuan Y. Prognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studies. Springerplus. 2016;5(1):1538. [PubMed ID: 27652111]. https://doi.org/10.1186/s40064-016-3225-y.

  • 37.

    Duan F, Wang K, Dai L, Zhao X, Feng Y, Song C, et al. Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies. Medicine (Baltimore). 2016;95(37):4773. [PubMed ID: 27631228]. https://doi.org/10.1097/MD.0000000000004773.

  • 38.

    Boro A, Bauer D, Born W, Fuchs B. Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma. Am J Cancer Res. 2016;6(2):544-52. [PubMed ID: 27186423].

  • 39.

    Wang X, Ning Y, Yang L, Liu H, Wu C, Wang S, et al. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Clin Exp Med. 2016. [PubMed ID: 27106278]. https://doi.org/10.1007/s10238-016-0422-5.

  • 40.

    Dai S, Lu Y, Long Y, Lai Y, Du P, Ding N, et al. Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis. Oncotarget. 2016;7(23):35369-78. [PubMed ID: 27177085]. https://doi.org/10.18632/oncotarget.9294.

  • 41.

    Shi C, Zhang Z. The prognostic value of the miR-200 family in ovarian cancer: a meta-analysis. Acta Obstet Gynecol Scand. 2016;95(5):505-12. [PubMed ID: 26910180]. https://doi.org/10.1111/aogs.12883.

  • 42.

    Wang N, Chen P, Huang LP, Wang TZ. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis. Genet Mol Res. 2016;15(2). [PubMed ID: 27173192]. https://doi.org/10.4238/gmr.15027350.